Intimation of Approval of Extension of time for holding Annual General Meeting (AGM) of the Company for the Financial Year ended on 31st March 2025, pursuant to Regulation 30 of SEBI (Listing ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genomic Valley Biotech Ltd has received approval from the Registrar of Companies (ROC), Delhi and Haryana, to extend the deadline for holding its Annual General Meeting (AGM) for the financial year ended 31st March 2025 by 3 months. The original AGM deadline of 30th September 2025 has now been pushed to 31st December 2025. The company had applied for this extension on 28th August 2025 citing difficulties faced in holding the meeting on time. The ROC granted the extension but warned the company to ensure timely compliance with AGM-related provisions in the future. The exact date of the new AGM will be communicated separately once decided by the Board of Directors.
This is a procedural/administrative filing and does not directly affect business fundamentals. However, the delay and the ROC's caution may raise minor governance concerns among investors about the company's compliance track record. Investors should watch for the AGM date announcement and any explanations provided at the meeting.